Genomic Health Inc (GHDX.O) Analysts | Reuters.com
Edition:
United States

Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

26.27USD
29 Jun 2016
Change (% chg)

-- (--)
Prev Close
$26.27
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
202,867
52-wk High
$35.79
52-wk Low
$20.05

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.17 December 30 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 2 2 2 2
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.29 2.29 2.29 2.29

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 11 81.22 82.00 80.50 82.41
Quarter Ending Sep-16 11 82.82 84.10 80.70 84.75
Year Ending Dec-16 13 330.03 333.03 327.00 336.23
Year Ending Dec-17 14 367.02 375.36 354.10 375.78
Earnings (per share)
Quarter Ending Jun-16 12 -0.17 -0.04 -0.22 -0.04
Quarter Ending Sep-16 11 -0.06 0.00 -0.15 0.00
Year Ending Dec-16 12 -0.45 -0.32 -0.59 0.05
Year Ending Dec-17 14 0.11 0.62 -0.10 0.43

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 78.12 80.89 2.77 3.55
Quarter Ending Sep-15 73.12 73.55 0.43 0.59
Quarter Ending Jun-15 71.65 70.62 1.03 1.44
Quarter Ending Mar-15 69.90 68.15 1.74 2.49
Quarter Ending Dec-14 72.04 69.13 2.92 4.05

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 81.22 81.22 81.22 80.09 82.41
Quarter Ending Sep-16 82.82 82.82 82.82 83.38 84.75
Year Ending Dec-16 330.03 330.03 330.29 327.29 336.23
Year Ending Dec-17 367.02 367.02 366.93 365.94 375.78

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 0 0
Quarter Ending Sep-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 1 0
Earnings

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.